Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression
Open accessThe DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Abstract
Depression is a highly prevalent mood disorder and one of the major health concerns in modern society. Moreover, it is characterized by a high prevalence of coexistence with many other diseases including metabolic disorders such as type 2 diabetes mellitus (T2DM) and obesity. Currently used antidepressant drugs, which mostly target brain monoaminergic neurotransmission, have limited clinical efficacy. Although the etiology of depression has not been fully elucidated, current scientific data emphasize the role of neurotrophic factors deficiencies, disturbed homeostasis between the nervous system and the immune and endocrine systems, as well as disturbances in brain energy metabolism and dysfunctions in the gut-brain axis as important factors in the pathogenesis of this neuropsychiatric disorder. Therefore, therapeutic options that could work in a way other than classic antidepressants are being sought to increase the effectiveness of the treatment. Interestingly, glucagon-like peptide-1 receptor agonists (GLP-1RAs), used in the treatment of T2DM and obesity, are known to show pro-cognitive and neuroprotective properties, and exert modulatory effects on immune, endocrine and metabolic processes in the central nervous system. This review article discusses the potential antidepressant effects of GLP-1RAs, especially in the context of their action on the processes related to neuroprotection, inflammation, stress response, energy metabolism, gut-brain crosstalk and the stability of the gut microbiota. Graphic abstract
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Malhi, G. S., & Mann, J. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31948-2 · Cited by 4,099
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371 · cited 1×
“At the same time, GLP-1 can also enhance the proliferation and differentiation of β cells and protect them from apoptosis [21].”
BackgroundZheng, P., Zeng, B., Zhou, C., Liu, M., Fang, Z., Xu, X., Zeng, L., Chen, J., Fan, S., Du, X., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.44 · Cited by 2,023 · cited 1×
“Similar results were observed in an experiment involving a germ-free mouse strain, where the animals transplanted with microbiome isolated from depressed patients showed an increase in immobility time in the forced swim test and a decreased proportion of central motion distance in the open field test, compared to mice…”
ResultGlucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868 · cited 1×
“GLP-1 exerts its biological effects by binding to a specific receptor (GLP-1R), which is expressed in different types of peripheral tissues and in the central nervous system [12].”
BackgroundThe microbiota in adaptive immune homeostasis and disease
Honda, K., & Littman, D. R. (2016) · Nature · doi:10.1038/nature18848 · Cited by 1,846 · cited 1×
“The gut microbiota may influence the functioning of the host organism by modulating innate and adaptive immune responses [105].”
BackgroundKelly, J. R., Borre, Y., O' Brien, C., Patterson, E., El Aidy, S., Deane, J., Kennedy, P. J., Beers, S., Scott, K., Moloney, G., et al. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.07.019 · Cited by 1,683 · cited 2×
“People with depression are often characterized by a significantly lower number of microorganisms in the GI tract along with a decreased diversity of the gut microbiome [99].”
BackgroundWang, P. S., Aguilar-Gaxiola, S., Alonso, J., Angermeyer, M. C., Borges, G., Bromet, E. J., Bruffaerts, R., de Girolamo, G., de Graaf, R., Gureje, O., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61414-7 · Cited by 1,655 · cited 1×
“76–85% of people living in low- or middle-income countries and suffering from this mental illness are not adequately treated [1].”
BackgroundNeuroinflammation and depression: A review
Troubat, R., Barone, P., Leman, S., Desmidt, T., Cressant, A., Atanasova, B., Brizard, B., El Hage, W., Surget, A., Belzung, C., et al. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14720 · Cited by 1,107
Depression and obesity: evidence of shared biological mechanisms
Milaneschi, Y., Simmons, W. K., van Rossum, E. F. C., & Penninx, B. W. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0017-5 · Cited by 1,073
Clinical and Biochemical Manifestations of Depression
Gold, P. W., Goodwin, F. K., & Chrousos, G. P. (1988) · New England Journal of Medicine · doi:10.1056/nejm198808183190706 · Cited by 1,053
Eng, J., Kleinman, W. A., Singh, L., Singh, G., & Raufman, J. P. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42531-8 · Cited by 1,000 · cited 1×
“They were developed on the basis of either human GLP-1 or exendin-4, a 39-amino acid peptide isolated from the Gila monster (Heloderma suspectum) venom, which shares 53% homology with GLP-1 [38].”
BackgroundDrucker, D. J., Philippe, J., Mojsov, S., Chick, W. L., & Habener, J. F. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3434 · Cited by 903 · cited 1×
“cAMP (EPAC) activation, which triggers the opening of voltage-dependent calcium channels (VDCCs), resulting in insulin exocytosis [24, 25].”
BackgroundMaes, M., Yirmyia, R., Noraberg, J., Brene, S., Hibbeln, J., Perini, G., Kubera, M., Bob, P., Lerer, B., & Maj, M. (2009) · Metabolic Brain Disease · doi:10.1007/s11011-008-9118-1 · Cited by 894
Pyke, C., Heller, R. S., Kirk, R. K., Ørskov, C., Reedtz-Runge, S., Kaastrup, P., Hvelplund, A., Bardram, L., Calatayud, D., & Knudsen, L. B. (2014) · Endocrinology · doi:10.1210/en.2013-1934 · Cited by 876
Dwivedi, Y., Rizavi, H. S., Conley, R. R., Roberts, R. C., Tamminga, C. A., & Pandey, G. N. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.8.804 · Cited by 875 · cited 1×
“For a long time, the manifestation of depressive symptoms has been also associated with the deficits in neurotrophic factor action in the brain [51], especially highlighting the role of diminished brain-derived neurotrophic factor (BDNF) signaling as important for the pathogenesis of this mental disorder [52].”
BackgroundGlucagon-like peptide-1 receptor is involved in learning and neuroprotection
During, M. J., Cao, L., Zuzga, D. S., Francis, J. S., Fitzsimons, H. L., Jiao, X., Bland, R. J., Klugmann, M., Banks, W. A., Drucker, D. J., et al. (2003) · Nature Medicine · doi:10.1038/nm919 · Cited by 851 · cited 1×
“It is noteworthy that a behavioral analysis of Glp1r +/+ , Glp1r +/− and Glp1r−/− mouse phenotypes and hippocampal Glp1r gene transfer demonstrated that deficiency of this receptor results in decrements in the acquisition of associative contextual learning which can be improved by hippocampal Glp1r somatic cell gene t…”
BackgroundA Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity
Kelly, A. S., Auerbach, P., Barrientos-Perez, M., Gies, I., Hale, P. M., Marcus, C., Mastrandrea, L. D., Prabhu, N., & Arslanian, S. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1916038 · Cited by 723 · cited 1×
“Lately, a GLP-1R agonist, liraglutide, has also been approved by the FDA for the treatment of adolescent obesity [14].”
BackgroundSemaglutide lowers body weight in rodents via distributed neural pathways.
Gabery, S., Salinas, C. G., Paulsen, S. J., Ahnfelt-Rønne, J., Alanentalo, T., Baquero, A. F., Buckley, S. T., Farkas, E., Fekete, C., Frederiksen, K. S., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.133429 · Cited by 717 · cited 1×
“Semaglutide on the other hand displays limited efficacy in crossing the BBB, but despite this fact it was proven to access the brainstem, septal nucleus and hypothalamus [42].”
BackgroundOyola, M. G., & Handa, R. J. (2017) · Stress · doi:10.1080/10253890.2017.1369523 · Cited by 710 · cited 1×
“Depressed patients are often characterized by elevated blood cortisol levels and changes in the circadian secretion of this hormone, an increased number of corticotropin-releasing hormone (CRH)-expressing neurons in the hypothalamic paraventricular nucleus (PVN), as well as an impairment in a negative feedback mechani…”
BackgroundMcClean, P. L., Parthsarathy, V., Faivre, E., & Hölscher, C. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0529-11.2011 · Cited by 698 · cited 1×
“In APP/PS1 mice, the cognitive improvement observed after ip administration of liraglutide was accompanied by decreased activation of microglia [66].”
BackgroundThe Role of Neural Plasticity in Depression: From Hippocampus to Prefrontal Cortex
Liu, W., Ge, T., Leng, Y., Pan, Z., Fan, J., Yang, W., & Cui, R. (2017) · Neural Plasticity · doi:10.1155/2017/6871089 · Cited by 640 · cited 1×
“The hippocampus, a brain structure associated with memory formation, seems to be particularly affected in depression [43, 44].”
BackgroundTissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor
Bullock, B. P., Heller, R. S., & Habener, J. F. (1996) · Endocrinology · doi:10.1210/en.137.7.2968 · Cited by 618
Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein
Zhang, Y., Sun, B., Feng, D., Hu, H., Chu, M., Qu, Q., Tarrasch, J. T., Li, S., Sun Kobilka, T., Kobilka, B. K., et al. (2017) · Nature · doi:10.1038/nature22394 · Cited by 576 · cited 1×
“This relatively small GPCR family is characterized by a long extracellular ligand-binding domain stabilized by three disulfide bridges formed by six highly conserved cysteine residues, seven α-helical transmembrane domains, universal for all GPCRs and an intracellular C-terminal domain, responsible mostly for receptor…”
BackgroundAnxiety, depression, and the microbiome: A role for gut peptides
Lach, G., Schellekens, H., Dinan, T. G., & Cryan, J. F. (2018) · Neurotherapeutics · doi:10.1007/s13311-017-0585-0 · Cited by 573
Glucocorticoids, cytokines and brain abnormalities in depression
Zunszain, P. A., Anacker, C., Cattaneo, A., Carvalho, L. A., & Pariante, C. M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.04.011 · Cited by 554
Role of Neurotrophic Factors in the Etiology and Treatment of Mood Disorders
Duman, R. S. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:1:011 · Cited by 537 · cited 1×
“For a long time, the manifestation of depressive symptoms has been also associated with the deficits in neurotrophic factor action in the brain [51], especially highlighting the role of diminished brain-derived neurotrophic factor (BDNF) signaling as important for the pathogenesis of this mental disorder [52].”
BackgroundAstrocytic Insulin Signaling Couples Brain Glucose Uptake with Nutrient Availability
García-Cáceres, C., Quarta, C., Varela, L., Gao, Y., Gruber, T., Legutko, B., Jastroch, M., Johansson, P., Ninkovic, J., Yi, C.-X., et al. (2016) · Cell · doi:10.1016/j.cell.2016.07.028 · Cited by 521 · cited 1×
“It was demonstrated, that metabolic disturbances in hypothalamic astrocytes, caused either by selective knock-out of insulin receptors or decreased generation of reactive oxygen species (ROS) modulated glucose transport via BBB and also led to modification in behavioral responses in experimental animals [95, 96].”
BackgroundHunter, K., & Hölscher, C. (2012) · BMC Neuroscience · doi:10.1186/1471-2202-13-33 · Cited by 504
Cork, S. C., Richards, J. E., Holt, M. K., Gribble, F. M., Reimann, F., & Trapp, S. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.07.008 · Cited by 478 · cited 1×
“Preproglucagon expressing neurons in the NTS project to many parts of the brain, including the hypothalamus, thalamus, parabrachial nucleus, parts of the mesolimbic dopamine system, raphe nucleus, amygdala, hippocampus and medial prefrontal cortex [32].”
BackgroundDepression in type 2 diabetes mellitus: prevalence, impact, and treatment
Semenkovich, K., Brown, M. E., Svrakic, D. M., & Lustman, P. J. (2015) · Drugs · doi:10.1007/s40265-015-0347-4 · Cited by 447 · cited 1×
“Moreover, depression is characterized by high prevalence of coexistence with many metabolic diseases, such as type 2 diabetes mellitus (T2DM) and obesity, and brain insulin resistance observed in both of these diseases is currently considered an important factor which may lead to the manifestation of depressive sympto…”
BackgroundNauck, M. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12591 · Cited by 429
Galley, J. D., Nelson, M. C., Yu, Z., Dowd, S. E., Walter, J., Kumar, P. S., Lyte, M., & Bailey, M. T. (2014) · BMC Microbiology · doi:10.1186/1471-2180-14-189 · Cited by 400 · cited 1×
“On the other hand, it was demonstrated that chronic stress in laboratory animals can shift the microbial diversity in the gastrointestinal tract [102, 103].”
BackgroundGut microbiome and depression: what we know and what we need to know
Winter, G., Hart, R. A., Charlesworth, R. P. G., & Sharpley, C. F. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0072 · Cited by 394 · cited 1×
“In the light of the current research, it is speculated that the maladaptive changes in the gut microbiota can influence the central nervous system and evoke depressive symptoms, and the development of depression can influence gut microbiome stability, and both of these hypotheses appear to be supported by the results…”
ResultMolecular adaptations of the blood–brain barrier promote stress resilience vs. depression
Dudek, K. A., Dion-Albert, L., Lebel, M., LeClair, K., Labrecque, S., Tuck, E., Ferrer Perez, C., Golden, S. A., Tamminga, C., Turecki, G., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1914655117 · Cited by 361 · cited 1×
“These results may suggest that GLP1R agonists may alleviate the blood–brain barrier breakdown induced by inflammatory factors, which is sometimes observed in depression [65].”
BackgroundEntry of exendin-4 into brain is rapid but may be limited at high doses
Kastin, A. J., & Akerstrom, V (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802206 · Cited by 355
Mitochondrial Dysfunction in Depression
Bansal, Y., & Kuhad, A. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160229114755 · Cited by 353
Mitochondria and Mood: Mitochondrial Dysfunction as a Key Player in the Manifestation of Depression
Allen, J., Romay-Tallon, R., Brymer, K. J., Caruncho, H. J., & Kalynchuk, L. E. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00386 · Cited by 347 · cited 1×
“Alterations in mitochondrial functions such as oxidative phosphorylation (OXPHOS) and membrane polarity, which enhance oxidative stress and apoptosis, may precede the development of depressive symptoms [84, 88, 89].”
BackgroundMalhi Gin, S., & John, M. J. (2018) · The Lancet · Cited by 332
Müller, M., Hernández, M. A. G., Goossens, G. H., Reijnders, D., Holst, J. J., Jocken, J. W. E., van Eijk, H., Canfora, E. E., & Blaak, E. E. (2019) · Scientific Reports · doi:10.1038/s41598-019-48775-0 · Cited by 324 · cited 1×
“Importantly, they can also convert indigestible carbohydrates into short-chain fatty acids (SCFA), which in turn activate specific G protein-coupled fatty acid (FFA) receptors, thereby promoting the secretion of peptide hormones from the enteroendocrine cells [106, 107].”
BackgroundThe gut microbiome composition associates with bipolar disorder and illness severity
Evans, S. J., Bassis, C. M., Hein, R., Assari, S., Flowers, S. A., Kelly, M. B., Young, V. B., Ellingrod, V. E., & McInnis, M. G. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.12.007 · Cited by 304
GLP-1 and weight loss: unraveling the diverse neural circuitry
Kanoski, S. E., Hayes, M. R., & Skibicka, K. P. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00520.2015 · Cited by 290 · cited 2×
“However, this anorexigenic action of GLP-1 is maintained through a complex neural circuitry and involves multiple brain areas [25, 31].”
BackgroundKopschina Feltes, P., Doorduin, J., Klein, H. C., Juárez-Orozco, L. E., Dierckx, R. A., Moriguchi-Jeckel, C. M., & de Vries, E. F. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117711708 · Cited by 279
Liu, Y., Zhao, J., & Guo, W. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.02201 · Cited by 261 · cited 1×
“On the other hand, in addition to the processes described above, it has been well established that neurotransmitters play a key role in behavior regulation and this is a clear relationship between their imbalance and specific symptoms of a major depressive disorder [55].”
BackgroundEarly-life stress and HPA axis trigger recurrent adulthood depression
Juruena, M. F. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.10.020 · Cited by 253 · cited 1×
“It is estimated that nearly 60% of depressive episodes are preceded by an exposure to various types of stressors [69].”
BackgroundSimon, M.-C., Strassburger, K., Nowotny, B., Kolb, H., Nowotny, P., Burkart, V., Zivehe, F., Hwang, J.-H., Stehle, P., Pacini, G., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2690 · Cited by 253 · cited 1×
“In a study involving healthy non-diabetic subjects, daily intake of a Lactobacillus reuteri SD5865 strain for 8 weeks resulted in an increase of GLP-1 secretion in the intestines, which was accompanied by elevated plasma insulin and C-peptide levels [109].”
BackgroundGut microbiota–brain axis in depression: the role of neuroinflammation
Carlessi, A. S., Borba, L. A., Zugno, A. I., Quevedo, J., & Réus, G. Z. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14631 · Cited by 243
Aoki, R., Kamikado, K., Suda, W., Takii, H., Mikami, Y., Suganuma, N., Hattori, M., & Koga, Y. (2017) · Scientific Reports · doi:10.1038/srep43522 · Cited by 225 · cited 1×
“In mice, treatment with a probiotic strain of Bifidobacterium elevated plasma levels of this hormone [108].”
BackgroundMontrose-Rafizadeh, C. (1999) · Endocrinology · doi:10.1210/en.140.3.1132 · Cited by 216
Astrocytic mitochondrial ROS modulate brain metabolism and mouse behaviour
Vicente-Gutierrez, C., Bonora, N., Bobo-Jimenez, V., Jimenez-Blasco, D., Lopez-Fabuel, I., Fernandez, E., Josephine, C., Bonvento, G., Enriquez, J. A., Almeida, A., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-018-0031-6 · Cited by 208 · cited 1×
“It was demonstrated, that metabolic disturbances in hypothalamic astrocytes, caused either by selective knock-out of insulin receptors or decreased generation of reactive oxygen species (ROS) modulated glucose transport via BBB and also led to modification in behavioral responses in experimental animals [95, 96].”
BackgroundHeppner, K. M., Kirigiti, M., Secher, A., Paulsen, S. J., Buckingham, R., Pyke, C., Knudsen, L. B., Vrang, N., & Grove, K. L. (2015) · Endocrinology · doi:10.1210/en.2014-1675 · Cited by 196
Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection
Hölscher, C. (2012) · CNS Drugs · doi:10.2165/11635890-000000000-00000 · Cited by 191 · cited 1×
“Therefore, GLP-1R agonists are currently being intensively studied for their use in the treatment of neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease [17, 18].”
BackgroundGLP-1: Molecular mechanisms and outcomes of a complex signaling system
Smith, N. K., Hackett, T. A., Galli, A., & Flynn, C. R. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.04.010 · Cited by 188 · cited 2×
“However, this anorexigenic action of GLP-1 is maintained through a complex neural circuitry and involves multiple brain areas [25, 31].”
BackgroundShan, Y., Tan, S., Lin, Y., Liao, S., Zhang, B., Chen, X., Wang, J., Deng, Z., Zeng, Q., Zhang, L., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1638-6 · Cited by 188 · cited 1×
“[64], which involved a co-culture of primary astrocytes with the bEnd.”
BackgroundGastrointestinal hormones and the dialogue between gut and brain
Dockray, G. J. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.270850 · Cited by 184 · cited 1×
“1 3 tract and the brain are involved in a complex bidirectional communication, which is mediated by the endocrine, immune and neural pathways, involving a plethora of different neurotransmitters, cytokines and peptide hormones [98].”
BackgroundPotential Prebiotic Properties of Almond (Amygdalus communis L.) Seeds
Mandalari, G., Nueno-Palop, C., Bisignano, G., Wickham, M. S. J., & Narbad, A. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.00739-08 · Cited by 171 · cited 1×
“In a clinical study involving patients with type 2 diabetes, an almond-based diet with a low-carbohydrate content, which had been previously shown to possess marked prebiotic properties [110, 111], resulted in augmentation of the number of SCFA-producing bacteria species, such as Roseburia, Ruminococcus and Eubacteriu…”
BackgroundAnderberg, R. H., Richard, J. E., Hansson, C., Nissbrandt, H., Bergquist, F., & Skibicka, K. P. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.11.021 · Cited by 170
Timper, K., del Río-Martín, A., Cremer, A. L., Bremser, S., Alber, J., Giavalisco, P., Varela, L., Heilinger, C., Nolte, H., Trifunovic, A., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.05.001 · Cited by 170 · cited 1×
“On the other hand, GLP-1R signaling in astrocytes was proven to be essential for maintaining mitochondrial integrity and function of the hypothalamic astrocytes, as deletion of GLP-1Rs resulted in the adaptive cellular stress response with the improvement of glucose metabolism and memory formation [97].”
BackgroundLiraglutide modulates gut microbiota and reduces NAFLD in obese mice
Moreira, G., Azevedo, F., Ribeiro, L., Santos, A., Guadagnini, D., Gama, P., Liberti, E., Saad, M., & Carvalho, C. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.07.009 · Cited by 156 · cited 1×
“Treatment with liraglutide was shown to modulate the diversity of the gut microbiota in experiments conducted on animals on a high-fat diet [113, 114].”
BackgroundZemdegs, J., Martin, H., Pintana, H., Bullich, S., Manta, S., Marqués, M. A., Moro, C., Layé, S., Ducrocq, F., Chattipakorn, N., et al. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.2904-18.2019 · Cited by 151 · cited 1×
“Metformin has been found to produce antidepressive effects by enhancing the responsiveness of the serotoninergic neurons in the dorsal raphe [47], but the main impact of GLP-1 is exerted by AMP-activated protein kinase (AMPK), a major cellular regulator of lipid and glucose metabolism [48].”
BackgroundForstner, A. J., Awasthi, S., Wolf, C., Maron, E., Erhardt, A., Czamara, D., Eriksson, E., Lavebratt, C., Allgulander, C., Friedrich, N., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-019-0590-2 · Cited by 146
Gaspersz, R., Nawijn, L., Lamers, F., & Penninx, B. W. J. H. (2018) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000376 · Cited by 139
Ren, M., Zhang, H., Qi, J., Hu, A., Jiang, Q., Hou, Y., Feng, Q., Ojo, O., & Wang, X. (2020) · Nutrients · doi:10.3390/nu12103036 · Cited by 139
Receptor‐mediated activation of gastric vagal afferents by glucagon‐like peptide‐1 in the rat
Bucinskaite, V., Tolessa, T., Pedersen, J., Rydqvist, B., Zerihun, L., Holst, J. J., & Hellström, P. M. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01317.x · Cited by 135 · cited 6×
“Preproglucagon expressing neurons in the NTS project to many parts of the brain, including the hypothalamus, thalamus, parabrachial nucleus, parts of the mesolimbic dopamine system, raphe nucleus, amygdala, hippocampus and medial prefrontal cortex [32].”
BackgroundInfluentialThe Effect of Low-Carbohydrate Diet on Glycemic Control in Patients with Type 2 Diabetes Mellitus
Wang, L.-L., Wang, Q., Hong, Y., Ojo, O., Jiang, Q., Hou, Y.-Y., Huang, Y.-H., & Wang, X.-H. (2018) · Nutrients · doi:10.3390/nu10060661 · Cited by 128 · cited 1×
“In a clinical study involving patients with type 2 diabetes, an almond-based diet with a low-carbohydrate content, which had been previously shown to possess marked prebiotic properties [110, 111], resulted in augmentation of the number of SCFA-producing bacteria species, such as Roseburia, Ruminococcus and Eubacteriu…”
BackgroundGlucagon-related peptide 1 (GLP-1): hormone and neurotransmitter
Larsen, P. J., & Holst, J. J. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.08.026 · Cited by 126 · cited 1×
“Distribution of GLP-1Rs in the brain is highly conserved in different mammalian species and pretty much correlates with the projection pattern of PPG-expressing neurons [33].”
BackgroundSzymańska, M., Budziszewska, B., Jaworska-Feil, L., Basta‐Kaim, A., Kubera, M., Leśkiewicz, M., Regulska, M., & Lasoń, W. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.12.012 · Cited by 125 · cited 1×
“Under a stress stimulus, the HPA axis becomes activated which results in the release of glucocorticoids [68].”
BackgroundSetoyama, D., Kato, T. A., Hashimoto, R., Kunugi, H., Hattori, K., Hayakawa, K., Sato-Kasai, M., Shimokawa, N., Kaneko, S., Yoshida, S., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0165267 · Cited by 125
Sarkar, S., Fekete, C., Légrádi, G., & Lechan, R. M. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03117-2 · Cited by 119
Neural effects of gut‐ and brain‐derived glucagon‐like peptide‐1 and its receptor agonist
Katsurada, K., & Yada, T. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12464 · Cited by 119 · cited 1×
“As an insulinotropic hormone, GLP-1 plays a substantial role in the regulation of glucose homeostasis, not only in the periphery but also in the central nervous system [90].”
BackgroundO'Neil, P. M., Aroda, V. R., Astrup, A., Kushner, R., Lau, D. C. W., Wadden, T. A., Brett, J., Cancino, A., Wilding, J. P. H., & groups, O. B. O. T. S. A. C. A. –. L. E. I. I. W. A. W. D. (. S. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12963 · Cited by 115
Weina, H., Yuhu, N., Christian, H., Birong, L., Feiyu, S., & Le, W. (2018) · Brain Research · doi:10.1016/j.brainres.2018.04.031 · Cited by 115
Katsurada, K., Maejima, Y., Nakata, M., Kodaira, M., Suyama, S., Iwasaki, Y., Kario, K., & Yada, T. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.116 · Cited by 112 · cited 1×
“Direct influence of GLP1R agonists on CRH expression was also observed in both an in vitro cellular model [73] and experimental animals [74].”
BackgroundKim, Y.-K., Kim, O. Y., & Song, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01270 · Cited by 109 · cited 1×
“Moreover, there are a few studies which indicate that these compounds may also prove useful in the treatment of neuropsychiatric disorders including depression [19, 20].”
BackgroundGLP-1 Influences Food and Drug Reward
Hayes, M. R., & Schmidt, H. D. (2016) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2016.02.005 · Cited by 108 · cited 1×
“Interestingly, GLP-1 is also known to decrease the rewarding effects of food intake by interacting with parts of the mesolimbic dopamine system such as the ventral tegmental area (VTA), nucleus accumbens (NAc) [34], and also GABAergic circuits in the laterodorsal tegmental nucleus (LDTg) [35], which makes brain GLP-1R…”
BackgroundGlucagon-like peptide-1 suppresses neuroinflammation and improves neural structure
Yoon, G., Kim, Y.-K., & Song, J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2019.104615 · Cited by 107 · cited 1×
“Moreover, treatment with GLP-1 resulted in a decrease of lipopolysaccharide (LPS)-induced activation of the BV-2 microglial cell line, accompanied by a decrease in TNF-α secretion [63].”
BackgroundBelzung, C. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.342 · Cited by 106 · cited 1×
“Therefore, therapeutic options that could work in a way other than classic antidepressants are being sought to increase the effectiveness of the depression treatment [2].”
BackgroundJi, C., Xue, G., Cao, L., Feng, P., Li, D., Li, L., Li, G., & Hölscher, C. (2015) · Brain Research · doi:10.1016/j.brainres.2015.09.035 · Cited by 105 · cited 1×
“For example, a novel dual agonist of GLP-1/GIP receptors significantly increased BDNF levels in a mouse model of Parkinson’s disease, induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration [53].”
BackgroundNeuroplasticity and major depression, the role of modern antidepressant drugs
Serafini, G. (2012) · World Journal of Psychiatry · doi:10.5498/wjp.v2.i3.49 · Cited by 103 · cited 1×
“The hippocampus, a brain structure associated with memory formation, seems to be particularly affected in depression [43, 44].”
BackgroundKorol, S. V., Jin, Z., Babateen, O., & Birnir, B. (2015) · Diabetes · doi:10.2337/db14-0668 · Cited by 101
Gault, V. A., Porter, W. D., Flatt, P. R., & Hölscher, C. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.59 · Cited by 99 · cited 1×
“Furthermore, it was demonstrated that GLP-1 receptor plays a regulatory role in the hippocampal function and GLP-1 receptor agonists enhanced GABAA signaling through pre-and postsynaptic mechanisms in rats [57], while exendin-4 therapy normalized cognitive dysfunction and improved impaired hippocampal synaptic plastic…”
BackgroundGLP-1(7-36)-amide and Exendin-4 Stimulate the HPA Axis in Rodents and Humans
Gil-Lozano, M., Pérez-Tilve, D., Alvarez-Crespo, M., Martís, A., Fernandez, A. M., Catalina, P. A. F., Gonzalez-Matias, L. C., & Mallo, F. (2010) · Endocrinology · doi:10.1210/en.2009-0915 · Cited by 93 · cited 1×
“The stimulatory effects of GLP-1 on the HPA axis were not limited to rodents; increased cortisol levels were observed in both healthy humans and type 1 diabetes patients to whom GLP-1 had been administered peripherally [76].”
BackgroundEffects of glucagon-like peptide 1 analogs on alcohol intake in alcohol-preferring vervet monkeys
Thomsen, M., Holst, J. J., Molander, A., Linnet, K., Ptito, M., & Fink-Jensen, A. (2019) · Psychopharmacology · doi:10.1007/s00213-018-5089-z · Cited by 93
Brain glucose metabolism in an animal model of depression
Detka, J., Kurek, A., Kucharczyk, M. W., Głombik, K., Basta‐Kaim, A., Kubera, M., Lasoń, W., & Budziszewska, B. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.03.046 · Cited by 92 · cited 1×
“Thus, metabolic changes may be key players in many disorders, including depression [91, 92].”
BackgroundSelf-citationBinge-type eating attenuates corticosterone and hypophagic responses to restraint stress
Kinzig, K. P., Hargrave, S. L., & Honors, M. A. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2008.04.026 · Cited by 89 · cited 1×
“It was demonstrated that GLP-1 brain administration elevated the circulating concentrations of the adrenocorticotropic hormone (ACTH) and corticosterone and also enhanced anxiety in behavioral measurements [75].”
BackgroundMcGovern, A. S., Hamlin, A. S., & Winter, G. (2019) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867419877954 · Cited by 89 · cited 1×
“Dysbiosis of the gut microbiome observed in depressed patients can also be caused by treatment with some antidepressant drugs due to their antimicrobial activity [104].”
Backgroundde Souza, A. G., Chaves Filho, A. J. M., Souza Oliveira, J. V., de Souza, D. A. A., Lopes, I. S., de Carvalho, M. A. J., de Lima, K. A., Florenço Sousa, F. C., Mendes Vasconcelos, S. M., Macedo, D., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.066 · Cited by 87 · cited 1×
“by decreasing immobility time in the forced swim test [54].”
BackgroundGlucagon-Like Peptide-1 (GLP-1) in the Integration of Neural and Endocrine Responses to Stress
Diz-Chaves, Y., Herrera-Pérez, S., González-Matías, L. C., Lamas, J. A., & Mallo, F. (2020) · Nutrients · doi:10.3390/nu12113304 · Cited by 84
Gut microbiome differences between metformin‐ and liraglutide‐treated T2 DM subjects
Wang, Z., Saha, S., Van Horn, S., Thomas, E., Traini, C., Sathe, G., Rajpal, D. K., & Brown, J. R. (2018) · Endocrinology, Diabetes & Metabolism · doi:10.1002/edm2.9 · Cited by 82 · cited 1×
“Similar results were found in a clinical study in patients with T2DM, where administration of liraglutide, but not metformin, increased the relative abundance of Akkermansia, which is often associated with the improvement of gastric mucosa and also becomes severely depleted in diabetic patients [115].”
ResultMoulton, C. D., Hopkins, C. W. P., Ismail, K., & Stahl, D. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.05.010 · Cited by 77
Batista, A. F., Bodart‐Santos, V., Felice, F. G. D., & Ferreira, S. T. (2018) · CNS Drugs · doi:10.1007/s40263-018-0593-6 · Cited by 77 · cited 1×
“Therefore, GLP-1R agonists are currently being intensively studied for their use in the treatment of neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease [17, 18].”
BackgroundOmics Studies of the Murine Intestinal Ecosystem Exposed to Subchronic and Mild Social Defeat Stress
Aoki-Yoshida, A., Aoki, R., Moriya, N., Goto, T., Kubota, Y., Toyoda, A., Takayama, Y., & Suzuki, C. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00262 · Cited by 74 · cited 1×
“On the other hand, it was demonstrated that chronic stress in laboratory animals can shift the microbial diversity in the gastrointestinal tract [102, 103].”
BackgroundMansur, R. B., Zugman, A., Ahmed, J., Cha, D. S., Subramaniapillai, M., Lee, Y. L., Lovshin, J. A., Lee, J. G., Lee, J.-H., Drobinin, V., et al. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.08.433 · Cited by 73 · cited 1×
“In a small-scale four-week long, open-label study involving 14 individuals diagnosed with major depressive disorder and bipolar disorder, which also displayed impaired executive function, treatment with liraglutide significantly reduced Hamilton Depression Rating Scale (HDRS) scores and improved executive function, ho…”
BackgroundTransmembrane signal transduction by peptide hormones via family B G protein-coupled receptors
Culhane, K. J., Liu, Y., Cai, Y., & Yan, E. C. Y. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00264 · Cited by 72 · cited 1×
“This relatively small GPCR family is characterized by a long extracellular ligand-binding domain stabilized by three disulfide bridges formed by six highly conserved cysteine residues, seven α-helical transmembrane domains, universal for all GPCRs and an intracellular C-terminal domain, responsible mostly for receptor…”
BackgroundChristensen, M., Sparre‐Ulrich, A. H., Hartmann, B., Grevstad, U., ROSENKILDE, M. M., Holst, J. J., Vilsbøll, T., & Knop, F. K. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.136 · Cited by 71
A randomized, controlled trial of liraglutide for adolescents with obesity
AS, K., P, A., M, B.-P., I, G., PM, H., C, M., LD, M., & N, P. (2020) · Yearbook of Paediatric Endocrinology · doi:10.1530/ey.17.11.12 · Cited by 67
Hernandez, N. S., Weir, V. R., Ragnini, K., Merkel, R., Zhang, Y., Mace, K., Rich, M. T., Christopher Pierce, R., & Schmidt, H. D. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00957-3 · Cited by 67 · cited 1×
“Interestingly, GLP-1 is also known to decrease the rewarding effects of food intake by interacting with parts of the mesolimbic dopamine system such as the ventral tegmental area (VTA), nucleus accumbens (NAc) [34], and also GABAergic circuits in the laterodorsal tegmental nucleus (LDTg) [35], which makes brain GLP-1R…”
BackgroundThe physiological role of the brain GLP-1 system in stress
Holt, M. K., & Trapp, S. (2016) · Cogent Biology · doi:10.1080/23312025.2016.1229086 · Cited by 63 · cited 1×
“Recently, in addition to the central maintenance of food intake, GLP-1R signaling has begun to be considered in the context of the regulation of the stress response, as it is indicated that it can activate both the hypothalamic–pituitary–adrenal (HPA) axis as well as the sympathetic nervous system [15, 16].”
BackgroundCentral GLP-1 receptors: Novel molecular targets for cocaine use disorder
Hernandez, N. S., & Schmidt, H. D. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.03.026 · Cited by 63
Millard, S. J., Weston-Green, K., & Newell, K. A. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109908 · Cited by 62 · cited 1×
“However, this particular rat strain is also widely regarded as a valid model of endogenous depression [117].”
BackgroundGlucocorticoid regulation of preproglucagon transcription and RNA stability during stress
Zhang, R., Packard, B. A., Tauchi, M., D'Alessio, D. A., & Herman, J. P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808716106 · Cited by 60
Wang, R.-F., Xue, G., Hölscher, C., Tian, M.-J., Feng, P., Zheng, J.-Y., & Li, D. (2018) · Epilepsy Research · doi:10.1016/j.eplepsyres.2018.03.009 · Cited by 58 · cited 1×
“Pretreatment with liraglutide (25 nmol/kg; ip) for 7 days resulted in the alleviation of mitochondrial stress induced by status epilepticus in the hippocampus of Sprague–Dawley rats [93].”
BackgroundVentorp, F., Bay-Richter, C., Nagendra, A. S., Janelidze, S., Matsson, V. S., Lipton, J., Nordström, U., Westrin, Å., Brundin, P., & Brundin, L. (2017) · Journal of Parkinson’s Disease · doi:10.3233/jpd-171068 · Cited by 56 · cited 1×
“In one study, it was demonstrated that exendin-4 prevented LPS-induced depressive-like symptoms in rats and displayed antidepressant-like properties measured in the forced swim test, but this effect was not mediated by the modulation of neuroinflammatory processes, since the levels of IL-1β and TNF-α were not affected…”
BackgroundAntiapoptotic Actions of Exendin-4 against Hypoxia and Cytokines Are Augmented by CREB
Velmurugan, K., Balamurugan, A. N., Loganathan, G., Ahmad, A., Hering, B. J., & Pugazhenthi, S. (2012) · Endocrinology · doi:10.1210/en.2011-1895 · Cited by 53 · cited 1×
“For example, exendin-4 at the concentration of 50 nM downregulated the expression of NF-κB p65 in isolated human pancreatic β cells [62].”
BackgroundMoulton, C. D., Pickup, J. C., Amiel, S. A., Winkley, K., & Ismail, K. (2015) · Primary care diabetes · doi:10.1016/j.pcd.2015.06.003 · Cited by 49 · cited 1×
“These results furthermore correlated with the reduction of CRP levels, which may suggest that anti-inflammatory action may be an important mechanism of the antidepressant effect of incretin-based drugs [121].”
Effect of Changing Milk and Yogurt Consumption on Human Nutrient Intake and Serum Lipoproteins
Massey, L. K. (1984) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(84)81297-7 · Cited by 49
Mansur, R. B., Lee, Y., Subramaniapillai, M., Brietzke, E., & McIntyre, R. S. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.048 · Cited by 47
Pozzi, M., Mazhar, F., Peeters, G. G. A. M., Vantaggiato, C., Nobile, M., Clementi, E., Radice, S., & Carnovale, C. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.05.044 · Cited by 47
Woo, Y. S., Lim, H. K., Wang, S., & Bahk, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186969 · Cited by 47 · cited 1×
“However, in contrast to anti-hyperlycemic agents such as metformin, pioglitazone and peroxisome proliferator-activated receptor gamma (PPARγ) agonists, which were particularly well studied in this matter, very few clinical studies concerning the effects of GLP-1R targeting therapeutics on alleviation of depressive sym…”
BackgroundImpaired Brain Energy Metabolism: Involvement in Depression and Hypothyroidism
Głombik, K., Detka, J., Kurek, A., & Budziszewska, B. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.586939 · Cited by 47
Self-citationMitochondrial Alterations and Neuropsychiatric Disorders
Marazziti, D., Baroni, S., Picchetti, M., Landi, P., Silvestri, S., Vatteroni, E., & Catena Dell'Osso, M. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711797379221 · Cited by 44 · cited 1×
“Alterations in mitochondrial functions such as oxidative phosphorylation (OXPHOS) and membrane polarity, which enhance oxidative stress and apoptosis, may precede the development of depressive symptoms [84, 88, 89].”
BackgroundHe, W., Wang, H., Zhao, C., Tian, X., Li, L., & Wang, H. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29204 · Cited by 43 · cited 1×
“isocitrate dehydrogenase, α-ketoglutarate dehydrogenase, and succinate dehydrogenase, and at the same time reduced generation of reactive oxygen species stabilized the mitochondrial membrane potential, enhanced the levels of ATP, and enhanced the activity of the mitochondrial complex I [94].”
BackgroundHe, P., Li, Z., Yue, Z., Gao, H., Feng, G., Wang, P., Huang, Y., Luo, W., Hong, H., Liang, L., et al. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.04.027 · Cited by 42
The supramammillary nucleus controls anxiety-like behavior; key role of GLP-1R
López-Ferreras, L., Eerola, K., Shevchouk, O. T., Richard, J. E., Nilsson, F. H., Jansson, L. E., Hayes, M. R., & Skibicka, K. P. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104720 · Cited by 39
Glucocorticoids suppress GLP-1 secretion: possible contribution to their diabetogenic effects
Kappe, C., Fransson, L., Wolbert, P., & Ortsäter, H. (2015) · Clinical Science · doi:10.1042/cs20140719 · Cited by 36 · cited 1×
“1 3 studies, administration of dexamethasone caused a reduction of GLP-1 secretion from the intestinal L cells [80] and also decreased the circulating levels of this peptide, which led to glucose intolerance and peripheral insulin resistance in rats [81].”
BackgroundPossible role of GLP-1 in antidepressant effects of metformin and exercise in CUMS mice
Liu, W., Liu, J., Huang, Z., Cui, Z., Li, L., Liu, W., & Qi, Z. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.12.112 · Cited by 35 · cited 1×
“Recent data have indicated that such an effect may depend on the influence on metabolic processes because in chronic unpredictable mild stress (CUMS) in mice, the decreased GLP-1 level in the hippocampus was increased with metformin treatment [46].”
BackgroundBrain Metabolic Alterations in Rats Showing Depression-Like and Obesity Phenotypes
Głombik, K., Detka, J., Góralska, J., Kurek, A., Solnica, B., & Budziszewska, B. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00131-w · Cited by 33 · cited 2×
“Alterations in mitochondrial functions such as oxidative phosphorylation (OXPHOS) and membrane polarity, which enhance oxidative stress and apoptosis, may precede the development of depressive symptoms [84, 88, 89].”
BackgroundSelf-citationBudziszewska, B. (2002) · PubMed · Cited by 32
Akimoto, H., Tezuka, K., Nishida, Y., Nakayama, T., Takahashi, Y., & Asai, S. (2019) · Pharmacology Research & Perspectives · doi:10.1002/prp2.536 · Cited by 32
Liraglutide for psychiatric disorders: clinical evidence and challenges
Camkurt, M. A., Lavagnino, L., Zhang, X. Y., & Teixeira, A. L. (2018) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2018-0031 · Cited by 31 · cited 1×
“Moreover, there are a few studies which indicate that these compounds may also prove useful in the treatment of neuropsychiatric disorders including depression [19, 20].”
BackgroundZhang, N., Tao, J., Gao, L., Bi, Y., Li, P., Wang, H., Zhu, D., & Feng, W. (2020) · BioMed Research International · doi:10.1155/2020/2947549 · Cited by 31 · cited 1×
“Treatment with liraglutide was shown to modulate the diversity of the gut microbiota in experiments conducted on animals on a high-fat diet [113, 114].”
BackgroundGil-Lozano, M., Romaní-Pérez, M., Outeiriño-Iglesias, V., Vigo, E., González-Matías, L. C., Brubaker, P. L., & Mallo, F. (2014) · Endocrinology · doi:10.1210/en.2013-1718 · Cited by 24 · cited 1×
“These data showed that subchronic (7 to 14 days) exendin-4 or liraglutide administration in rodents resulted in hyperactivation of the HPA, disruption of glucocorticoid circadian secretion, hypertrophy of the adrenal gland, and dysregulation of pituitary-adrenal stress responses [77].”
BackgroundO’Brien, R., & O’Malley, D. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13738 · Cited by 24 · cited 1×
“Administration of exendin-4 ameliorated stress-induced defecation, decreased visceral pain sensitivity and increased the serum level of anti-inflammatory cytokine: interleukin-13 in the Wistar–Kyoto rat strain, which was considered a model for irritable bowel syndrome [116].”
BackgroundOwji, A. A., Khoshdel, Z., Sanea, F., Panjehshahin, M. R., Fard, M. S., Smith, D. M., Coppock, H. A., Ghatei, M. A., & Bloom, S. R. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03379-0 · Cited by 18
Winzeler, B. F., da Conceição, I., Refardt, J. C., Sailer, C. O., Dutilh, G., & Christ‐Crain, M. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01420 · Cited by 18 · cited 1×
“Conversely, in a recent randomized, double-blind, placebo-controlled study involving twenty healthy volunteers, a once-weekly injection of a GLP-1R agonist, dulaglutide, for three weeks did not influence HPA axis activity, showing no significant effects on circadian rhythms of blood or salivary cortisol secretion, and…”
BackgroundSato, T., Hayashi, H., Hiratsuka, M., & Hirasawa, N. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.02.014 · Cited by 15 · cited 1×
“1 3 studies, administration of dexamethasone caused a reduction of GLP-1 secretion from the intestinal L cells [80] and also decreased the circulating levels of this peptide, which led to glucose intolerance and peripheral insulin resistance in rats [81].”
BackgroundNguyen, T., Gong, M., Wen, S., Yuan, X., Wang, C., Jin, J., & Zhou, L. (2020) · Journal of Diabetes Research · doi:10.1155/2020/4727390 · Cited by 15 · cited 1×
“Metformin has been found to produce antidepressive effects by enhancing the responsiveness of the serotoninergic neurons in the dorsal raphe [47], but the main impact of GLP-1 is exerted by AMP-activated protein kinase (AMPK), a major cellular regulator of lipid and glucose metabolism [48].”
BackgroundKageyama, K., Yamagata, S., Akimoto, K., Sugiyama, A., Murasawa, S., & Suda, T. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.06.023 · Cited by 13 · cited 1×
“Direct influence of GLP1R agonists on CRH expression was also observed in both an in vitro cellular model [73] and experimental animals [74].”
BackgroundDetka, J., Ślusarczyk, J., Kurek, A., Kucharczyk, M. W., Adamus, T., Konieczny, P. S., Kubera, M., Basta‐Kaim, A., Lasoń, W., & Budziszewska, B. (2018) · Pharmacological Reports · doi:10.1016/j.pharep.2018.11.001 · Cited by 13 · cited 1×
“In our studies conducted in a prenatal stress model (PS) of depression in rats, adult PS animals showed a significant decrease in GLP-1R protein levels in the hippocampus after the acute immobility stress [83].”
BackgroundSelf-citationMotivation: A factor in denture treatment
Collett, H. A. (1967) · Journal of Prosthetic Dentistry · doi:10.1016/0022-3913(67)90044-3 · Cited by 10
GLP-1R activation alters performance in cognitive tasks in a sex-dependent manner
Trammell, T. S., Henderson, N. L., Madkour, H. S., Stanwood, G. D., & Graham, D. L. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04910-8 · Cited by 10 · cited 1×
“Studies on mice demonstrated that administration of exendin-4 (ip) prior to cognitive tests enhanced performance during difficult probe tests but only in females [50].”
Background
Cited by
Hassamal, S. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1130989 · Cited by 578
“Furthermore, emerging data supports that glucagon-like peptide-1 (GLP-1) agonists, such as liraglutide, have pro-cognitive, neuroprotective, and antidepressant effects (32).”
BackgroundThe gut microbiome and mental health: advances in research and emerging priorities
Shoubridge, A. P., Choo, J. M., Martin, A. M., Keating, D. J., Wong, M., Licinio, J., & Rogers, G. B. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01479-w · Cited by 145
“In addition to its role in regulating feeding behaviour [106], therapeutic targeting of GLP-1 signalling via GLP-1 receptors is now being considered in the context of mood disorders and neurodegenerative diseases (reviewed by Detka and Glombik [107]).”
BackgroundGlucagon-Like Peptide 1 Receptor Agonists and Mental Health: A Systematic Review and Meta-Analysis
Pierret, A. C. S., Mizuno, Y., Saunders, P., Lim, E., De Giorgi, R., Howes, O. D., McCutcheon, R. A., McGowan, B., Sen Gupta, P., Smith, D., et al. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2025.0679 · Cited by 116
GLP-1 Receptor Agonist Use and Risk of Suicide Death
Ueda, P., Söderling, J., Wintzell, V., Svanström, H., Pazzagli, L., Eliasson, B., Melbye, M., Hviid, A., & Pasternak, B. (2024) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2024.4369 · Cited by 103
Tobaiqy, M., & Elkout, H. (2024) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-023-01694-7 · Cited by 88
“Neuropsychiatric safety issues have become an area of interest given that many approved anti-obesity medications are centrally acting appetite suppressants [18, 19].”
Background
Metadata
- Authors
- Detka, J., & Głombik, K.
- Affiliations
- Maj Institute of Pharmacology (PL)
- Corresponding author
- Detka, Jan
- Venue
- Pharmacological Reports
- Published
- 2021-05-18
- Volume
- 73
- Issue
- 4
- Pages
- 1020-1032
- ISSN
- 1734-1140 (ISSN-L)
- 2299-5684
- PMC
- PMC8413152
- OpenAlex
- W3162613451
- Cited by
- 79
- References
- 130
- Citations by year
- 2026: 10 · 2025: 34 · 2024: 16 · 2023: 10 · 2022: 8 · 2021: 1
- FWCI
- 1.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Pharmacological Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Instytut Farmakologii, Polskiej Akademii Nauk (Statutory Funds)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- GLP-1 receptor agonists, depression, antidepressant effects, neuroprotection, neuroinflammation, stress response, brain energy metabolism, gut-brain axis, gut microbiota, type 2 diabetes, obesity, neurotrophic factors
- MeSH terms
- Neuroprotection, Gastrointestinal Microbiome, Glucagon-Like Peptide-1 Receptor Agonists, Animals, Antidepressive Agents, Depression, Energy Metabolism, Humans, Inflammation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.